Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in metabolic research. It is supplied as a lyophilized powder (5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 80 mg, 100 mg per vial) for in-vitro and laboratory research. Each lot is manufactured under controlled conditions and verified by independent third-party testing before release.
Specifications
- Purity: ≥ 99% (HPLC)
- Identity confirmed by MS
- Available sizes: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 80 mg, 100 mg
- Batch number and certificate of analysis supplied with every order
Storage & handling
Store lyophilized at −20 °C. After reconstitution keep refrigerated at 2–8 °C. Protect from light.
This product is intended strictly for laboratory research. It is not a drug, food or cosmetic and is not for human or veterinary use.
